RSC Advances
Paper
pressure and the residue was dissolved in MeOH (150 mL).
NaBH4 (4.24 g, 112 mmol) was added portionwise to the solu-
tion at 0 ꢀC and stirred at room temperature for 5 days. Aer the
reaction mixture was acidied by addition of HCl aq., MeOH
was removed under reduced pressure and the aqueous phase
was extracted with CHCl3. The organic phase was washed with
sat. NaHCO3 aq. and dried over anhydrous Na2SO4. The solvent
was removed under reduced pressure and the residue was
puried by silica gel column chromatography (hexane–EtOAc ¼
10 : 1). Further recrystallization from hexane afforded rac-1b
(4.74 g, 19.0 mmol, 85%) as a colorless needle crystal. Mp: 104–
Single crystal X-ray analyses
X-ray crystallographic data were collected on a Bruker Smart
APEX II diffractometer with graphite monochromated Mo-Ka
radiation. The structures were solved by a direct method using
SIR 97 (ref. 20) and rened by SHELXL-97 or SHELXL-2013
programs.21 Crystal data for rac-1b: C16H27NO, M ¼ 249.39,
˚
monoclinic, a ¼ 15.4268(18), b ¼ 9.5663(11), c ¼ 11.1965(13) A,
3
ꢀ
˚
b ¼ 105.9770(10) , V ¼ 1588.5(3) A , T ¼ 150 K, space group P21/
c, Z ¼ 4, 2789 reections measured, 2366 independent reec-
tions (Rint ¼ 0.1447). The nal R1 was 0.0755 (I > 2s(I)) and
wR(F2) was 0.2066 (I > 2s(I)). Crystal data for (S)-1a$6$0.5H2O:
1
ꢀ
106 C. H NMR (300 MHz, CDCl3): d 7.22–7.21 (m, 1H), 6.85–
6.84 (m, 1H), 4.31 (q, J ¼ 6.6 Hz, 1H), 1.49 (d, J ¼ 6.6 Hz, 3H),
1.43 (s, 9H), 1.29 (s, 9H). 13C NMR (125 MHz, CDCl3): d 154.2,
140.2, 136.5, 127.2, 122.7, 122.0, 52.5, 35.0, 34.2, 31.7, 29.7, 23.7.
IR (KBr): nmax 3371, 3300, 2954, 2871, 1601, 1587, 1479, 1440,
C
22H26NO4.5, M ¼ 376.44, monoclinic, a ¼ 23.818(8), b ¼
3
ꢀ
˚
˚
5.5862(18), c ¼ 15.671(5) A, b ¼ 113.803(4) , V ¼ 1907.8(11) A ,
T ¼ 150 K, space group C2, Z ¼ 4, 2980 reections measured,
2690 independent reections (Rint ¼ 0.0979). The nal R1 was
0.0590 (I > 2s(I)) and wR(F2) was 0.1577 (I > 2s(I)). Crystal data
1361, 1252, 1232, 1053, 880, 820 cmꢂ1
.
for 1b$7: C21H34N2O4, M ¼ 378.50, monoclinic, a ¼ 16.749(4),
3
ꢀ
˚
˚
b ¼ 8.124(2), c ¼ 17.552(4) A, b ¼ 116.504(3) , V ¼ 2137.2(9) A ,
T ¼ 150 K, space group P21, Z ¼ 4, 5394 reections measured,
4024 independent reections (Rint ¼ 0.1078). The nal R1 was
0.0814 (I > 2s(I)) and wR(F2) was 0.2084 (I > 2s(I)). Crystal data
for (R)-1b$5: C34H41NO9, M ¼ 607.68, monoclinic, a ¼ 29.287(5),
General procedure for the diastereomeric resolution of rac-1
An equimolar amounts of 1 and each resolving agent (0.5 mmol
for 1a and 0.3 mmol for 1b) were dissolved in methanol. Aer
concentration, the diastereomeric salts were recrystallized from
an appropriate solvent and the precipitated salt was collected by
ltration and dried under reduced pressure. The yield was
calculated based on a half amount of rac-1 initially used. (S)-
ꢀ
˚
b ¼ 7.6383(12), c ¼ 18.538(4) A, b ¼ 126.490(4) , V ¼ 3333.9(10)
3
˚
A , T ¼ 150 K, space group C2, Z ¼ 4, 5298 reections measured,
4235 independent reections (Rint ¼ 0.1093). The nal R1 was
0.0495 (I > 2s(I)) and wR(F2) was 0.1021 (I > 2s(I)).†
1
1a$6. H NMR (300 MHz, CDCl3–CD3OD): d 7.72–7.69 (m, 3H),
7.46–7.43 (m, 1H), 7.17–7.11 (m, 3H), 7.02–6.99 (m, 1H), 6.83–
6.77 (m, 2H), 4.32 (q, J ¼ 6.9 Hz, 1H), 3.92 (s, 3H), 3.82 (q, J ¼ 7.2
Hz, 1H), 1.56 (d, J ¼ 7.2 Hz, 3H), 1.49 (d, J ¼ 6.9 Hz, 3H). 1b$5.
1H NMR (300 MHz, CDCl3–CD3OD): d 8.13 (d, J ¼ 8.1 Hz, 4H),
7.61–7.56 (m, 2H), 7.48–7.43 (m, 4H), 7.26 (s, 1H), 6.99 (s. 1H),
5.96 (s, 2H), 4.53–4.47 (m, 1H), 1.52 (d, J ¼ 6.3 Hz, 3H), 1.39 (s,
Notes and references
1 (a) H. Pellissier, Recent Developments in Asymmetric
Organocatalysis, Royal Society of Chemistry, Cambridge,
2010; (b) Catalytic Asymmetric Synthesis, ed. I. Ojima, Wiley,
Weinheim, Germany, 3rd edn, 2010.
1
9H), 1.28 (s, 9H). 1b$7. H NMR (300 MHz, CDCl3–CD3OD): d
7.28 (d, J ¼ 2.4 Hz, 1H), 7.05 (d, J ¼ 2.4 Hz, 1H), 4.56 (q, J ¼ 6.9
Hz, 1H), 4.18–4.13 (m, 1H), 2.54–2.30 (m, 3H), 2.22–2.11 (m,
1H), 1.74 (d, J ¼ 6.9 Hz, 3H), 1.43 (s, 9H), 1.30 (s, 9H).
To determine the enantiomeric excess of resolved 1a, a small
amount of the salt was added in 1 N HCl aq. and washed with
CHCl3, and the solution was basied by addition of NaHCO3.
The aqueous phase was extracted with EtOAc and dried over
anhydrous Na2SO4. Aer removal of the solvent, 1a was
obtained as a solid. Resolved 1a was quantitatively derivatized
to its acetamide in the presence of acetic anhydride, of which
the enantiomeric excess was determined by a HPLC analysis
(Daicel ChiralPak OD-3, hexane–2-propanol ¼ 9 : 1, 1.0 mL
minꢂ1, tr(R) ¼ 13.4 min; tr(S) ¼ 15.3 min).
2 (a) J. Jacques, A. Collet and S. H. Wilen, Enantiomers,
Racemates, and Resolutions, Krieger Publishing Company,
Malabar, Florida, 1994; (b) D. Kozma, Optical Resolutions
via Diastereomeric Salt Formation, CRC Press, London,
´
´
´
2002; (c) F. Faigl, E. Fogassy, M. Nogradi, E. Palovics and
J. Schindler, Tetrahedron: Asymmetry, 2008, 19, 519–536; (d)
R. Siedlecka, Tetrahedron, 2013, 69, 6331–6363.
3 (a) R. M. Kellogg, J. W. Nieuwenhuijzen, K. Pouwer,
T. R. Vries, Q. B. Broxterman, R. F. P. Grimbergen,
B. Kaptein, R. M. La Crois, E. de Wever, K. Zwaagstra and
A. C. van der Laan, Synthesis, 2003, 1626–1638; (b)
M. Leeman, G. Brasile, E. Gelens, T. Vries, B. Kaptein and
R. Kellogg, Angew. Chem., Int. Ed., 2008, 47, 1287–1290; (c)
P. Wang, E. Zhang, P. Zhao, Q. Ren, Y. Guan and H. Liu,
Chirality, 2012, 24, 1013–1017; (d) L. R. Nassimbeni, H. Su
and T. Curtin, Chem. Commun., 2012, 48, 8526–8528.
4 (a) R. Sakurai, A. Yuzawa, K. Sakai and N. Hirayama, Cryst.
Growth Des., 2006, 6, 1606–1610; (b) K. Taniguchi,
M. Aruga, M. Yasutake and T. Hirose, Org. Biomol. Chem.,
2008, 6, 458–463; (c) K. Kodama, Y. Kimura, H. Shitara,
M. Yasutake, R. Sakurai and T. Hirose, Chirality, 2011, 23,
326–332; (d) R. Sakurai, K. Sakai, K. Kodama and
M. Yamaura, Tetrahedron: Asymmetry, 2012, 23, 221–224; (e)
The salt of 1b was added in 1 N NaOH aq. and extracted with
EtOAc due to the low solubility of 1b in an aqueous phase. The
extract was washed with sat. NaHCO3 aq., water and dried over
anhydrous Na2SO4. Aer removal of the solvent, 1b was
obtained as a solid. The enantiomeric excess of resolved 1b was
determined by a HPLC analysis (Daicel ChiralPak OJ-3, hexane–
2-propanol ¼ 97 : 3, 0.5 mL minꢂ1, tr(S) ¼ 11.8 min; tr(R) ¼ 15.7
min). The absolute congurations were determined by
comparison with the products prepared according to the
literature.10b
25614 | RSC Adv., 2014, 4, 25609–25615
This journal is © The Royal Society of Chemistry 2014